Small cell carcinoma of the prostate
β Scribed by Paul G. Hagood; Frank E. Johnson; Carlos W. M. Bedrossian; Alan B. Silverberg
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 540 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
This report details clinical and pathologic aspects of a patient with small cell undifferentiated carcinoma of the prostate and systemic hyperglucagonemia. A panel of potential serologic markers was evaluated in order to document additional evidence of ectopic hormonal production. Immunocytochemical markers were sought in tissue samples from the primary neoplasm and a lung metastasis. Stains were positive for corticotropin (ACTH) and gastrin in both the prostate and in the lung, but no evidence of excess secretion was documented. These findings are consistent with the notion that neuroendocrine activity is common in undifferentiated small cell carcinomas, regardless of their site of origin.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The current study was conducted to determine the clinical characteristics and prognostic features associated with prostatic small cell carcinoma (SCC). ## METHODS. Between January 1985 and May 2005, 83 patients with SCC of the prostate were identified. Univariate and m
over a 23-year period were reviewed. Patient's ages ranged from 30 to 89 years (median, 67 years). In nine cases, pure adenocarcinoma of the prostate preceeded recognition of the small cell component by 7 months to 8 years (median, 18 monthsk five of these were initially at Stage A. There was a smal
Numerous ectopic hormones and markers have been described in small cell carcinoma of the lung as well as in extrapulmonary small cell carcinomas. The authors report a case of a patient with metastatic small cell carcinoma of unknown primary who had very high prostatic acid phosphatase (PAP) and pros